Promising new drug may help teens regrow hair lost to severe alopecia
Disease control
Recruiting now
This study tests a drug called deuruxolitinib in teens aged 12 to 17 with severe alopecia areata, a condition causing significant scalp hair loss. Participants must have at least 50% hair loss and will receive either the drug or a placebo for 24 weeks, followed by an open-label p…
Phase: PHASE3 • Sponsor: Sun Pharmaceutical Industries, Inc. • Aim: Disease control
Last updated May 17, 2026 11:30 UTC